Myocardial infarction research reveals immune-driven cardiac damage. Learn how targeting NK cells could improve heart ...

(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...

Median overall survival increased by >40% in elraglusib arm compared to the control arm, with a 1-year survival rate of 44% in the elraglusib ...

I initiate coverage on Forte Biosciences stock at a 'Hold' rating due to both pipeline risk and upcoming clinical catalysts.

Ferrocene-modified covalent organic frameworks combine sonodynamic therapy with immune activation to suppress primary breast ...

Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that ...

BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...

Amid a renaissance in the science of psychedelics, public interest in psilocybin – or magic mushrooms, as they’ve long been ...

Preliminary Q1 2026 net product revenue of approximately $44.2 million, representing an ~168% year-over-year increase ...

Augusta National is pretty specific about maintaining its traditions, and that comes with a set of rules written in stone.

Consistent survival benefit observed across the poorest prognosis patient subgroups, including those with liver metastases and high disease burden 7-40X increases in tumor-infiltrating cytotoxic ...

Surgery for lingering post-covid symptoms saved the life of Giles Blair who had no idea just how unwell he really was ...